{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:42:50Z","timestamp":1791344570196,"version":"4.3.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:00:00Z","timestamp":1492819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["heliyon.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.heliyon.2017.e00333","type":"journal-article","created":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:46:20Z","timestamp":1498275980000},"page":"e00333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The response to Typhi Vi vaccination is compromised in individuals with primary immunodeficiency"],"prefix":"10.1016","volume":"3","author":[{"given":"Jeevani","family":"Kumarage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suranjith L.","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijitha","family":"Senaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitha","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirthi","family":"Gunasekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandu","family":"Gunasena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmalal","family":"Gurugama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudath","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony R.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilhan Rajiva","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2017.e00333_bib0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaci.2008.09.021","article-title":"Antibody response to pneumococcal vaccination as a function of preimmunization titer","volume":"123","author":"Hare","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0015","doi-asserted-by":"crossref","first-page":"e4854","DOI":"10.1097\/MD.0000000000004854","article-title":"Serotype 6B from a pneumococcal polysaccharide vaccine induces cross-functional antibody responses in adults to serotypes 6A, 6C, and 6D","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.heliyon.2017.e00333_bib0020","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1016\/j.vaccine.2011.09.078","article-title":"Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model","volume":"29","author":"Skinner","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2017.e00333_bib0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1099\/00221287-138-2-297","article-title":"The Vi antigen of Salmonella typhi: molecular analysis of the viaB locus","volume":"138","author":"Kolyva","year":"1992","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.2004.02439.x","article-title":"Development of an anti-Salmonella Typhi Vi ELISA: assessment of immunocompetence in healthy donors","volume":"136","author":"Ferry","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0035","first-page":"ESID","article-title":"Concentration of IgG antibodies specific to Salmonella Typhi Vi in adult blood donors","volume":"34","author":"Parker","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clim.2016.05.006","article-title":"Multicenter study for the evaluation of the antibody response against Salmonella Typhi Vi vaccination (EMPATHY) for the diagnosis of anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency","volume":"169","author":"Sanchez-Ramon","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)","volume":"93","author":"Conley","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2249.2006.03138.x","article-title":"Clinical Working Party of the European Society for I. Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists","volume":"145","author":"de Vries","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2249.2011.04461.x","article-title":"European Society for Immunodeficiencies m. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update","volume":"167","author":"de Vries","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/1744666X.2014.875274","article-title":"New diagnostic criteria for CVID","volume":"10","author":"Ameratunga","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0065","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fimmu.2017.00546","article-title":"Fifth percentile cutoff values for antipneumococcal polysaccharide and anti-Salmonella Typhi Vi IgG describe a normal polysaccharide Response","volume":"8","author":"Schaballie","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2017.e00333_bib0070","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2249.2006.03242.x","article-title":"The clinical syndrome of specific antibody deficiency in children","volume":"146","author":"Boyle","year":"2006","journal-title":"Clin. Exp. Immunol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844017309416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844017309416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T12:31:29Z","timestamp":1535718689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844017309416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2405844017309416"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2017.e00333","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The response to Typhi Vi vaccination is compromised in individuals with primary immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2017.e00333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e00333"}}